Coronary atherosclerotic disease burden: An emerging endpoint in progression/regression studies using intravascular ultrasound

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 3, Issue 3, 2003, Pages 218-226

  Schoenhagen, Paul ^a,b   Nissen, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cardiovascular Imaging Center   (United States)

Author keywords

Atherosclerosis imaging; Intravascular ultrasound; Plaque burden; Plaque vulnerability; Progression; Regression

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; RAPAMYCIN;

ACUTE DISEASE; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CAUSE OF DEATH; CLINICAL OBSERVATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; INTRAVASCULAR ULTRASOUND; MORPHOLOGY; NON INVASIVE MEASUREMENT; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PREVALENCE; PRIMARY PREVENTION; QUANTITATIVE ANALYSIS; RESTENOSIS; REVIEW; SUDDEN DEATH; SYMPTOMATOLOGY; WESTERN EUROPE;

CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0041471610     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006033481401     Document Type: Review

References (108)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association 2001.
2. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). European Heart Journal, 2002, 23, 1190-1201.
3. Bonow, R.O. Primary Prevention of Cardiovascular Disease. A Call to Action. Circulation, 2002, 106, 3140-3141.
4. Schwartz, G.G., Olsson, A.G., Ezekowitz, M.D., Ganz, P., Oliver, M.F., Waters, D., Zeiher, A., Chaitman, B.R., Leslie, S. and Stern, T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study. JAMA, 2001, 285, 1711-8.
5. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. and Dagenais, G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med., 2000, 342, 145-153.
6. Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G. and Fox, K.K. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med., 2001, 345, 494-502.
7. Ambrose, J.A., Tannenbaum, M.A., Alexopoulos, D., Hjemdahl-Monsen, C.E., Leavy, J., Weiss, M., Borrico, S., Gorlin, R. and Fuster, V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol., 1988, 12, 56-62.
8. Burke, A.P., Farb, A., Malcom, G.T., Liang, Y.H., Smialek, J. and Virmani, R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med., 1997, 336, 1276-82.
9. Falk, E., Shah, P.K. and Fuster, V. Coronary plaque disruption. Circulation 1995, 92, 657-671.
10. Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation, 2001, 104, 365-372.
11. Strong, J.P., Malcom, G.T., McMahan, C.A., Tracy, R.E., Newman, W.P. 3rd, Herderick, E.E. and Cornhill, J.F. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from pathobiological determinants of atherosclerosis in youth study. JAMA, 1999, 281, 727-35.
12. Tuzcu, E.M., Kapadia, S.R., Tutar, E., Ziada, K.M., Hobbs, R.E., McCarthy, P.M., Young, J.B. and Nissen, S.E. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation, 2001, 103, 2705-2710.
13. Kannell, W.B., Castelli, W.P., Gordon, T. and McNamara, P.M. Serum cholesterol, lipoproteins, and the reish of coronary heart disease: The Framingham Study. Ann. Intern. Med., 1971, 74, 1-12.
14. Castelli, W.P. Epidemiology of coronary heart disease: the Framingham Study. Am. J. Med., 1984, 76, 4-12.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
16. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. JAMA, 1984, 251, 365-374.
17. Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F. and Furberg, C.D. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation, 1995, 91, 2274-82.
18. Brown, B.G., Albers, J.J., Fisher, L.D., Schaefer, S.M., Lin, J.-T., Kaplan, C., Zhao, X.Q., Bisson, B.D., Fitzpatrick, V.F. and Dodge, H.T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med., 1990, 323, 1289-1298.
19. Downs, J.R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D.R., Beere, P.A., Langendorfer, A., Stein, E.A., Kruyer, W., Gotto, A.M. Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). JAMA, 1998, 279, 1615-1622.
20. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 subjects with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 334, 1383-1389.
21. Sacks, F.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M., Wun, C.C., Davis, B.R. and Braunwald, E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med., 1996, 335, 1001-1009.
22. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H. and Packard, C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Eng. J. Med., 1995, 333, 1301-1307.
23. Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F. and Furberg, C.D. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation, 1998, 97, 946-52.
24. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. and Hennekens, C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 1997, 336, 973-9.
25. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. and Cook, N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med., 2002, 347, 1557-65.
26. Fayad, Z.A., Fuster, V., Nikolaou, K. and Becker, C. Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts. Circulation, 2002, 106, 2026-2034.
27. Fayad, Z.A. and Fuster, V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ. Res., 2001, 89, 305-16.
28. Blankenhorn, D.H., Azen, S.P., Kramsch, D.M., Mack, W.J., Cashen-Hemphill, L., Hodis, H.N., DeBoer, L.W., Mahrer, P.R., Masteller, M.J., Vailas, L.I., et al. Coronary angiographic changes with lovastatin therapy. The monitored atherosclerosis regression study (MARS). Ann. Inter. Med., 1993, 119, 969-976.
29. MAAS Investigators. Effect of Simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet, 1994, 344, 633-638.
30. Pitt, B., Mancini, G.B., Ellis, S.G., Rosman, H.S., Park, J.-S. and McGovern, M.E. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. J. Am. Coll. Cardiol., 1995, 26, 1133-1139.
31. Schartl, M., Bocksch, W., Koschyk, D.H., Voelker, W., Karsch, K.R., Kreuzer, J., Hausmann, D., Beckmann, S. and Gross, M. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation, 2001, 104, 387-392.
32. Callister, T.Q., Raggi, P., Cooil, B., Lippolis, N.J. and Russo, D.J. Effect of HMG-CoA reductase inhibitors on coronary artery disease by electron-beam computed tomography. N. Engl. J. Med., 1998, 339, 1972-8.
33. Achenbach, S., Ropers, D., Pohle, K., Leber, A., Thilo, C., Knez, A., Menendez, T., Maeffert, R., Kusus, M., Regenfuss, M., Bickel, A., Haberl, R., Steinbeck, G., Moshage, W. and Daniel, W.G. Influence of lipid-lowering therapy on the progression of coronary artery calcification. Circulation, 2002, 106, 1077-1082.
34. de Groot, E., Jukema, J.W., Montauben van Swijndregt, A.D., Zwinderman, A.H., Ackerstaff, R.G., van der Steen, A.F., Bom, N., Lie, K.I. and Bruschke, A.V. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlation with coronary arteriogarphic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J. Am. Coll. Cardiol., 1998, 31, 1561-7.
35. Taylor, A.J., Kent, S.M., Flaherty, P.J., Coyle, L.C., Markwood, T.T. and Vernalis, M.N. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol. A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness. Circulation, 2002, 106, 2055-2060.
36. MacMahon, S., Sharpe, N., Gamble, G., Hart, H., Scott, J., Simes, J. and White, H. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID Atherosclerosis Substudy. Circulation, 1998, 97, 1784-90.
37. Corti, R., Fayad, Z.A., Fuster, V., Worthley, S.G., Helft, G., Chesebro, J., Mercuri, M. and Badimon, J.J. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation, 2001, 104, 249-52.
38. Zhao, X.Q., Yuan, C., Hatsukami, T.S., Frechette, E.H., Kang, X.J., Maravilla, K.R. and Brown, B.G. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 1623-1629.
39. Nabel, E.G., Selwyn, A.P. and Ganz, P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J. Am. Coll. Cardiol., 1990, 16, 349-56.
40. de Jongh, S., Lilien, M.R., op't Roodt, J., Stroes, E.S.G., Bakker, H.D., Kastelein, J.J.P.. Early Statin Therapy Restores Endothelial Function in Children With Familial Hypercholeserolemia. J. Am. Coll. Cardiol., 2002, 40, 2117-2121.
41. Takiuchi, S., Rakugi, H., Honda, K., Masuyama, T., Hirata, N., Ito, H., Sugimoto, K., Yanagitani, Y., Moriguchi, K., Okamura, A., Higaki, J. and Ogihara, T. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation, 2000, 102, 766-70.
42. Nair, A., Kuban, B.D., Tuzcu, E.M., Schoenhagen, P., Nissen, S.E. and Vince, D.G. Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis. Circulation, 2002, 106, 2200-2206.
43. Stahr, P.M., Hofflinghaus, T., Voigtlander, T., Courtney, B.K., Victor, A., Otto, M., Yock, P.G., Brennecke, R. and Fitzgerald, P.J. Discrimination of early/intermediate and advanced/complicated coronary plaque types by radiofrequency intravascular ultrasound analysis. Am. J. Cardiol., 2002, 90, 19-23.
44. de Korte, C.L., Pasterkamp, G., van der Steen, A.F., Woutman, H.A. and Bom, N. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation, 2000, 102, 617-623.
45. Yabushita, H., Bouma, B.E., Houser, S.L.H., Aretz, H.T., Jang, I.K., Schlendorf, K.H., Kauffman, C.R., Shishkov, M., Kang, D.H., Halpern, E.F. and Tearney, G.J. Characterization of Human Atherosclerosis by Optical Coherence Tomography. Circulation, 2002, 106, 1640-1645.
46. Guillermo, J.T., Yabushita, H., Houser, S.L., Aretz, H.T., Jang, I.K., Schlendorf, K.H., Kauffman, C.R., Shishkov, M., Halpern, E.F. and Bouma, B.E. Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography. Circulation, 2003, 107, 113-119.
47. Casscells, W., Hathorn, B., David, M., Krabach, T., Vaughn, W.K., McAllister, H.A., Bearman, G. and Willerson, J.T. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet, 1996, 347, 1447-51.
48. Stefanadis, C., Diamantopoulos, L., Vlachopoulos, C., Tsiamis, E., Dernellis, J., Toutouzas, K., Stefanadi, E. and Toutouzas, P. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation, 1999, 99, 1965-71.
49. Brown, B.G., Bolson, E., Frimer, M. and Dodge, H.T. Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation, 1977, 55, 329-37.
50. Keane, D., Haase, J., Slager, C.J., Montauban van Swijndregt, E., Lehmann, K.G., Ozaki Y, di Mario C, Kirkeeide R, Serruys PW. Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. Circulation, 1995, 91, 2174-83.
51. Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S.J. and Lesperance, J. Effects of monotherapy with HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed be serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial (CCAIT). Circulation, 1994, 89, 959-968.
52. Jukema, J.W., Bruschke, A.V., van Boven, A.J., Reiber, J.H., Bal, E.T., Zwinderman, A.H., Jansen, H., Boerma, G.J., van Rappard, F.M. and Lie, K.I. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation, 1995, 91, 2528-40.
53. Brown, G., Albers, J.J., Fisher, L.D., Schaefer, S.M., Lin, J.T., Kaplan, C., Zhao, X.Q., Bisson, B.D., Fitzpatrick, V.F., Dodge, H.T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med., 1990, 323, 1289-98.
54. Serruys, P.W.J.C., de Feyter, P., Macaya, C., Kokott, N., Puel, J., Vrolix, M., Branzi, A., Bertolami, M.C., Jackson, G., Strauss, B. and Meier, B. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. JAMA, 2002, 287, 3215-3222.
55. Arnett, E.N., Isner, J.M., Redwood, C.R., Kent, K.M., Baker, W.P., Ackerstein, H. and Roberts, W.C. Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necropsy findings. Ann. Intern Med., 1979, 91, 350-356.
56. Grodin, C.M., Dydra, I., Pastgernac, A., Campeau, L. and Bourassa, M.G. Discrepancies between cineangiographic and post-mortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation, 1974, 49, 703-709.
57. Topol, E.J. and Nissen, S.E. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation, 1995, 92, 2333-42.
58. Mintz, G.S., Painter, J.A., Pichard, A.D., Kent, K.M., Satler, L.F., Popma, J.J., Chuang, Y.C., Bucher, T.A., Sokolowicz, L.E., Leon, M.B. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J. Am. Coll. Cardiol., 1995, 25, 1479-1485.
59. Buffon, A., Biasucci, L.M., Liuzzo, G., D'Onofrio, G., Crea, F. and Maseri, A. Widespread coronary inflammation in unstable angina. N. Engl. J. Med., 2002, 347, 5-12.
60. Glagov, S., Weisenberg, E., Zarins, C.K., Stankunavicius, R. and Kolettis, G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med., 1987; 316, 1371-5.
61. Schoenhagen, P., Ziada, K.M., Vince, D.G., Nissen, S.E. and Tuzcu, E.M. Arterial Remodeling and Coronary Artery Disease. The Concept of "Dilated" versus "Obstructive" Coronary Atherosclerosis. JACC, 2001, 38, 297-306.
62. McPherson, D.D., Hiratzka, L.F., Lamberth, W.C., Brandt, B., Hunt, M., Kieso, R.A., Marcus, M.L, and Kerber, R.E. Delineation of the extent of coronary atherosclerosis by high frequency epicardial echocardiography. N. Engl. J. Med., 1987, 316, 304-9.
63. Ge, J., Liu, F., Gorge, G., Haude, M., Baumgart, D. and Erbel, R. Angiographically 'silent' plaque in the left main coronary artery detected by intravascular ultrasound. Coron. Artery Dis., 1995, 6, 805-10.
64. Hermiller, J.B., Tenaglia, A.N., Kisslo, K.B., Phillips, H.R., Bashore, T.M., Stack, R.S., Davidson, C.J. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am. J. Cardiol., 1993, 71, 665-668.
65. Pasterkamp, G., Schoneveld, A.H., van der Wal, A.C., Haudenschild, C.C., Clarijs, R.J.G., Becker, A.E., Hillen, B., Borst, C. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: The remodeling paradox. J. Am. Coll. Cardiol., 1998, 32, 655-62.
66. Burke, A.P., Kolodgie, F.D., Farb, A., Weber, D. and Virmani, R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation, 2002, 105, 297-303.
67. Varnava, A.M., Mills, P.G., Davies, M.J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation, 2002, 105, 939-943.
68. Little, W.C., Constantinescu, M., Applegate, R.J., Kutcher, M.A., Burrows, M.T., Kahl, F.R. and Santamore, W.P. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation, 1988, 78, 1157-1166.
69. Schoenhagen, P., Ziada, K.M., Kapadia, S.R., Crowe, T.D., Nissen, S.E. and Tuzcu, E.M. Extent and direction of arterial remodeling in stable and unstable coronary syndromes. Circulation, 2000, 101, 598-603.
70. Yamagishi, M., Terashima, M., Awano, K., Kijima, M., Nakatani, S., Daikoku, S., Ito, K., Yasumura, Y. and Miyatake, K. Morphology of vulnerable coronary plaque: Insights from follow-up of patients examined by intravascular ultrasound before and acute coronary syndrome. J. Am. Coll. Cardiol., 2000, 35, 106-11.
71. Mintz, G.S., Nissen, S.E., Anderson, W.D., Bailey, S.R., Erbel, R., Fitzgerald, P.J., Pinto, F.J., Rosenfield, K., Siegel, R.J., Tuzcu, E.M. and Yock, P.G. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol., 2001, 37, 1478-92.
72. Di Mario, C., Gorge, G., Peters, R., Kearney, P., Pinto, F., Hausmann, D., von Birgelen, C., Colombo, A., Mudra, H., Roelandt, J. and Erbel, R. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur. Heart J., 1998, 19, 207-229.
73. Nissen, S.E. Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am. J. Cardiol., 2002, 89, 24B-31B.
74. Mehran, R., Mintz, G.S., Hong, M.K., Tio, F.O., Bramwell, O., Brahimi, A., Kent, K.M., Pichard, A.D., Satler, L.F., Popma, J.J. and Leon, M.B. Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J. Am. Coll. Cardiol., 1998, 32, 794-9.
75. Prati, F., Di Mario, C., Moussa, I., Reimers, B., Mallus, M.T., Parma, A., Lioy, E. and Colombo, A. In-stent neointimal proliferation correlates with the amount of residual plaque burden outside the stent: an intravascular ultrasound study. Circulation, 1999, 99, 1011-4.
76. Kay, I.P., Wardeh, A.J., Kozuma, K., Foley, D.P., Knook, A.H., Thury, A., Sianos, G., van der Giessen, W.J., Levendag, P.C., Serruys, P.W. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation, 2001, 103, 14-7.
77. Sousa, J.E., Costa, M.A., Abizaid, A.C., Rensing, B.J., Abizaid, A.S., Tanajura, L.F., Kozuma, K., Van Langenhove, G., Sousa, A.G., Falotico, R., Jaeger, J, Popma, J.J., Serruys, P.W. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation, 2001, 104, 2007-11.
78. Honda, Y., Grube, E., de La Fuente, L.M., Yock, P.G., Stertzer, S.H., Fitzgerald, P.J. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation, 2001, 104, 380-3.
79. Serruys, P.W., Degertekin, M., Tanabe, K., Abizaid, A., Sousa, J.E., Colombo, A., Guagliumi, G., Wijns, W., Lindeboom, W.K., Ligthart, J., de Feyter, P.J. and Morice, M.C. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation, 2002, 106, 798-803.
80. Maehara, A., Patel, N.S., Harrison, L.B., Weissman, N.J., Bui, A.B., Kim, H.S. Ajani, A.E., Castagna, M.T., McMillan, T.L., Yang, N., Chan, R., Pisch, J., Quan, H., Chiu-Tsao, S.T., Waksman, R., Mintz, G.S. Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric study. J. Am. Coll. Cardiol., 2002, 39, 1937-42.
81. Costa, M.A., Sabate, M., Serrano, P., van der Giessen, W.J., Kozuma, K, Kay, I.P., Coen, V.L., Ligthart, J.M., Wardeh, A., Levendag, P.C. Serruys, P.W. The effect of 32P beta-radiotherapy on both vessel remodeling and neointimal hyperplasia after coronary balloon angioplasty and stenting: a three-dimensional intravascular ultrasound investigation. J. Invasive Cardiol., 2000, 12, 113-20.
82. Albiero, R., Adamian, M, Kobayashi, N., Amato, A., Vaghetti, M,Di., Mario, C., Colombo, A. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study. Circulation, 2000, 101, 18-26.
83. Kapadia, S.R., Nissen, S.E., Ziada, K.M., Guetta, V., Crowe, T.D., Hobbs, R.E., Starling, R.C., Young, J.B. and Tuzcu, E.M. Development of transplantation vasculopathy and progression of donor- transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. Circulation, 1998, 98, 2672-2678.
84. Hosenpud, J.D., Bennett, L.E., Keck, B.M., Boucek, M.M. and Novick, R.J. The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J. Heart Lung Transplant, 2001, 20, 805-15.
85. Meisner, B.M., Billingham, M.E. and Morris, R.E. Effects of cyclosporine, FK506, and rapamycin on graft vessel disease. Lancet, 1991, 338, 1297-1298.
86. Kobashigawa, J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy. Curr. Control Trials Cardiovasc. Med., 2000, 1, 166-171.
87. Tuzcu, E.M, Schoenhagen, P., Starling, R.C., Hobbs, R.E., Dorent R, Pulpon L, Simonsen S, Taylor DO, Kobashigawa J, Abeywickrama KH, Popovich J, Magyar W, Nissen SE. Impact of everolimus on allograft vasculopathy. The SDZ Rad/heart intravascular ultrosound study. J. Heart and Lung Transplantation, 2002, 21, 68 abstract.
88. Tsutsui, H., Schoenhagen, P, Klingensmith, J.D., Vince, D.G., Nissen, S.E, Tuzcu, E.M. Regression of a donor atheroma after cardiac transplantation: serial observations with intravascular ultrasound. Circulation, 2001, 104, 2874.
89. Takagi, T., Yoshida, K., Akasaka, T., Hozumi, T., Morioka, S., Yoshikawa., J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am. J. Cardiol., 1997, 79, 1673-1676.
90. Matsuzaki, M., Hiramori, K., Imaizumi, T., Kitabatake, A., Hishida, H., Nomura, M., Fuji, T., Sakuma, I., Fukami, K., Honda, T., Ogawa, H. and Yamagichi, M. Intravascualar ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia. J. Am. Coll. Cardiol., 2002, 40, 220-7.
91. Hausmann, D., Erbel, R., Alibelli-Chemarin, M.J., Boksch, W., Caracciolo, E., Cohn, J.M., Culp, S.C., Daniel, W.G., De Scheerder, I., DiMario, C., Ferguson, JJ. III, Fitzgerald, P.J., Friedrich, G., Ge, J., Görge, G., Hanrath, P., Hodgson, J.McB., Isner, J.M., Jain, S., Maier-Rudolph, W., Mooney, M., Moses, J.W., Mudra, H., Pinto, F.J., Smalling, R.W., Talley, J.D., Tobis, J.M. Walter, P.D., Weidinger, F., Werner, G.S., Yeung, A.C., Yock, P.G. The safety of intracoronary ultrasound: a multicenter survey of 2207 examinations. Circulation, 1995, 91, 623-630.
92. Halliburton, S.S., Stillman, A.E. and White, R.D. Non-Invasive Quantification of Coronary Artery Calcification: A Potential Tool for the Assessment of Coronary Artery Disease in Patients with Chronic Renal Failure. Cleve. Clin. J. Med., 2002, 69, Suppl 3, S6-11
93. O'Rourke, R.A., Brundage, B.H., Froelicher, V.F., Greenland, P., Grundy, S.M., Hachamovitch, R., Pohost, G.M., Shaw, L.J., Weintraub, W.S., Winters, W.L. Jr, Forrester, J.S., Douglas, P.S., Faxon, D.P., Fisher, J.D., Gregoratos, G., Hochman, J.S., Huffer, A.M. Jr, Kaul, S., Wolk, M.J. American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery Disease. Circulation, 2000, 102, 126-140.
94. Nieman, K., Cademartiri, F., Lemos, P.A., Raaijmakers, R., Pattynama, P.M.T. and de Feyter, P.J. Reliable Noninvasive Coronary Angiography With Fast Submillimeter Multislice Spiral Computed Tomography. Circulation, 2002, 106, 2051-2054.
95. Schroeder, S., Kopp, A.F., Baumbach, A., Meisner, C., Kuettner, A., Georg, C., Ohnesorge, B., Herdeg, C., Claussen, C.D. and Karsch, K.R. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J. Am. Coll. Cardiol., 2001, 37, 1430-1435.
96. Salonen, J.T., Korpela, H., Salonen, R. and Nyyssonen, K. Precision and reproducibility of ultrasonographic measurement of progression of common carotid artery atherosclerosis. Lancet, 1993, 341, 1158-1159.
97. Salonen, R., Tervahauta, M., Salonen, J.T., Pekkanen, J., Nissinen, A. and Karvonen, M.J. Ultrasonographic manifestations of common carotid atherosclerosis in elderly eastern Finnish men. Prevalence and associations with cardiovascular diseases and risk factors. Arterioscler. Thromb., 1994, 10, 1631-1640.
98. Ferrieres, J., Elias, A., Ruidavets, J.B., Cantet, C., Bongard, V., Fauvel, J. and Boccalon, H. Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J. Hypertens., 1999, 17, 743-748.
99. Espeland, M.A., Tang, R., Terry, J.G., Davis, D.H., Mercuri, M. and Crouse, J.R. III. Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery. Stroke, 1999, 5, 1047-1055.
100. Olsen, M.H., Fossum, E., Hjerkinn, E., Wachtell, K., Hoieggen, A., Nesbitt, S.D., Andersen, U.B., Phillips, R.A., Gaboury, C.L., Ibsen, H., Kjeldsen, S.E. and Julius, S. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE substudy. Insulin Carotids US Scandinavia. J. Hypertens, 2000, 18, 75-81.
101. Howard, G., Sharrett, A.R., Heiss, G., Evans, G.W., Chambless, L.E., Riley, W.A. and Burke, G.L. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke, 1993, 9, 1297-1304.
102. Davis, P.H., Dawson, J.D., Mahoney, L.T. and Lauer, R.M. Increased carotid intima-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation, 1999, 100, 832-842.
103. Salonen, J.T. and Salonen, R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler. Thromb., 1991, 11, 1245-1249.
104. Chambless, L.E., Heiss, G., Folsom, A.R., Rosamond, W., Szklo, M., Sharrett, A.R. and Clegg, L.X. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am. J. Epidemiol., 1997, 146, 483-494.
105. Chambless, L.E., Folsom, A.R., Clegg, L.X. Sharrett, A.R., Shahar, E., Nieto, F.J., Rosamond, W.D. and Evans, G. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol., 2000, 151, 478-487.
106. O'Leary, D.H., Polak, J.F., Kronmal, R.A., Manolio, T.A., Burke, G.L. and Wolfson, S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New Engl. J. Med., 1999, 340, 14-22.
107. Bots, M.L., Hoes, A.W., Koudstaal, P.J., Hofman, A. and Grobbee, D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997, 96, 1432-1437.
108. Hodis, H.N., Mack, W.J., LaBree, L., Selzer, R.H., Liu, C.R., Liu, C.H. and Azen, S.P. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med., 1998, 128, 262-269.